Brief: Alphamab Oncology Says From July 14-16 Directors And Senior Management Bought 900,000 Shares
17/07/2025 05:27
July 17 (Reuters) - Alphamab Oncology 9966.HK: FROM JULY 14-16 DIRECTORS AND SENIOR MANAGEMENT BUY 900,000 SHARES AT HK$7.257 Further company coverage: 9966.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)